| ■ 영문 제목 : Global Second Generation Cephalosporins Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2108K201815 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 184 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (20명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 2세대 세팔로스포린의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (세포티암, 세푸록심)와 용도별 시장규모 (호흡기 감염, 이비인후과 감염, 요로 감염, 피부 및 연조직 감염, 뼈 및 관절 감염, 임질, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 2세대 세팔로스포린 시장 점유율 - 지역별 2세대 세팔로스포린 시장규모 - 주요지역의 종류별 시장규모 (세포티암, 세푸록심) - 주요지역의 용도별 시장규모 (호흡기 감염, 이비인후과 감염, 요로 감염, 피부 및 연조직 감염, 뼈 및 관절 감염, 임질, 기타) - 미주의 2세대 세팔로스포린 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 2세대 세팔로스포린 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 2세대 세팔로스포린 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 2세대 세팔로스포린 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 2세대 세팔로스포린 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Second Generation Cephalosporins will have significant change from previous year. By the most conservative estimates of global Second Generation Cephalosporins market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Second Generation Cephalosporins market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Second Generation Cephalosporins market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Cefotiam
Cefuroxime
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Respiratory Tract Infection
Otolaryngological Infection
Urinary Tract Infection
Skin and Soft Tissue Infections
Bone and Joint Infections
Gonorrhea
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Apotex
Esseti Farmaceutici
GSK
Lilly
Medochemie
Northeast Pharmaceutical
NCPC
Nanchang Lijian Pharmaceutical
Sichuan Pharmaceutical
Shandong Runze Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangdong Bozhou Pharmaceutical
Guangdong Jincheng Jinsu Pharmaceutical
Guangzhou Baiyunshan Tianxin Pharmaceutical
Guangxi Kelun Pharmaceutical
Yuekang Pharmaceutical Group
Shantou Jinshi Injection
Zhejiang Yatai Pharmaceutical
Shenzhen Xinlitai Pharmaceutical
Shenzhen Huarun Jiuxin Pharmaceutical
Zhuhai Union Pharmaceutical
Ruiyang Pharmaceutical
Fujian Fukang Pharmaceutical
Suzhou Erye Pharmaceutical
Furen Pharmaceutical Group
Chongqing Kerui Pharmaceutical Group
Shanxi Xidunsi Pharmaceutical
Qilu Pharmaceutical
Shandong Zibo Xinda Pharmaceutical
Guangzhou Nanxin Pharmaceutical
1 Scope of the Report 2 Executive Summary 3 Global Second Generation Cephalosporins by Company 4 Second Generation Cephalosporins by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Second Generation Cephalosporins Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Second Generation Cephalosporins Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Cefotiam Table 3. Major Players of Cefuroxime Table 4. Global Second Generation Cephalosporins Sales by Type (2016-2021) & (KG) Table 5. Global Second Generation Cephalosporins Sales Market Share by Type (2016-2021) Table 6. Global Second Generation Cephalosporins Revenue by Type (2016-2021) & ($ million) Table 7. Global Second Generation Cephalosporins Revenue Market Share by Type (2016-2021) Table 8. Global Second Generation Cephalosporins Sale Price by Type (2016-2021) Table 9. Global Second Generation Cephalosporins Sales by Application (2016-2021) & (KG) Table 10. Global Second Generation Cephalosporins Sales Market Share by Application (2016-2021) Table 11. Global Second Generation Cephalosporins Value by Application (2016-2021) Table 12. Global Second Generation Cephalosporins Revenue Market Share by Application (2016-2021) Table 13. Global Second Generation Cephalosporins Sale Price by Application (2016-2021) Table 14. Global Second Generation Cephalosporins Sales by Company (2019-2021) & (KG) Table 15. Global Second Generation Cephalosporins Sales Market Share by Company (2019-2021) Table 16. Global Second Generation Cephalosporins Revenue by Company (2019-2021) ($ Millions) Table 17. Global Second Generation Cephalosporins Revenue Market Share by Company (2019-2021) Table 18. Global Second Generation Cephalosporins Sale Price by Company (2019-2021) Table 19. Key Manufacturers Second Generation Cephalosporins Producing Area Distribution and Sales Area Table 20. Players Second Generation Cephalosporins Products Offered Table 21. Second Generation Cephalosporins Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Second Generation Cephalosporins Sales by Region (2016-2021) (KG) Table 25. Global Second Generation Cephalosporins Sales Market Share by Region (2016-2021) Table 26. Global Second Generation Cephalosporins Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Second Generation Cephalosporins Revenue Market Share by Region (2016-2021) Table 28. Americas Second Generation Cephalosporins Sales by Country (2016-2021) & (KG) Table 29. Americas Second Generation Cephalosporins Sales Market Share by Country (2016-2021) Table 30. Americas Second Generation Cephalosporins Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Second Generation Cephalosporins Revenue Market Share by Country (2016-2021) Table 32. Americas Second Generation Cephalosporins Sales by Type (2016-2021) & (KG) Table 33. Americas Second Generation Cephalosporins Sales Market Share by Type (2016-2021) Table 34. Americas Second Generation Cephalosporins Sales by Application (2016-2021) & (KG) Table 35. Americas Second Generation Cephalosporins Sales Market Share by Application (2016-2021) Table 36. APAC Second Generation Cephalosporins Sales by Region (2016-2021) & (KG) Table 37. APAC Second Generation Cephalosporins Sales Market Share by Region (2016-2021) Table 38. APAC Second Generation Cephalosporins Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Second Generation Cephalosporins Revenue Market Share by Region (2016-2021) Table 40. APAC Second Generation Cephalosporins Sales by Type (2016-2021) & (KG) Table 41. APAC Second Generation Cephalosporins Sales Market Share by Type (2016-2021) Table 42. APAC Second Generation Cephalosporins Sales by Application (2016-2021) & (KG) Table 43. APAC Second Generation Cephalosporins Sales Market Share by Application (2016-2021) Table 44. Europe Second Generation Cephalosporins Sales by Country (2016-2021) & (KG) Table 45. Europe Second Generation Cephalosporins Sales Market Share by Country (2016-2021) Table 46. Europe Second Generation Cephalosporins Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Second Generation Cephalosporins Revenue Market Share by Country (2016-2021) Table 48. Europe Second Generation Cephalosporins Sales by Type (2016-2021) & (KG) Table 49. Europe Second Generation Cephalosporins Sales Market Share by Type (2016-2021) Table 50. Europe Second Generation Cephalosporins Sales by Application (2016-2021) & (KG) Table 51. Europe Second Generation Cephalosporins Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Second Generation Cephalosporins Sales by Country (2016-2021) & (KG) Table 53. Middle East & Africa Second Generation Cephalosporins Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Second Generation Cephalosporins Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Second Generation Cephalosporins Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Second Generation Cephalosporins Sales by Type (2016-2021) & (KG) Table 57. Middle East & Africa Second Generation Cephalosporins Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Second Generation Cephalosporins Sales by Application (2016-2021) & (KG) Table 59. Middle East & Africa Second Generation Cephalosporins Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Second Generation Cephalosporins Table 61. Key Application and Potential Industries of Second Generation Cephalosporins Table 62. Key Challenges of Second Generation Cephalosporins Table 63. Key Trends of Second Generation Cephalosporins Table 64. Second Generation Cephalosporins Distributors List Table 65. Second Generation Cephalosporins Customer List Table 66. Global Second Generation Cephalosporins Sales Forecast by Region (2021-2026) & (KG) Table 67. Global Second Generation Cephalosporins Consumption Market Forecast by Region Table 68. Global Second Generation Cephalosporins Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Second Generation Cephalosporins Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Second Generation Cephalosporins Sales Forecast by Country (2021-2026) & (KG) Table 71. Americas Second Generation Cephalosporins Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Second Generation Cephalosporins Sales Forecast by Region (2021-2026) & (KG) Table 73. APAC Second Generation Cephalosporins Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Second Generation Cephalosporins Sales Forecast by Country (2021-2026) & (KG) Table 75. Europe Second Generation Cephalosporins Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Second Generation Cephalosporins Sales Forecast by Country (2021-2026) & (KG) Table 77. Middle East & Africa Second Generation Cephalosporins Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Second Generation Cephalosporins Sales Forecast by Type (2021-2026) & (KG) Table 79. Global Second Generation Cephalosporins Sales Market Share Forecast by Type (2021-2026) Table 80. Global Second Generation Cephalosporins Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Second Generation Cephalosporins Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Second Generation Cephalosporins Sales Forecast by Application (2021-2026) & (KG) Table 83. Global Second Generation Cephalosporins Sales Market Share Forecast by Application (2021-2026) Table 84. Global Second Generation Cephalosporins Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Second Generation Cephalosporins Revenue Market Share Forecast by Application (2021-2026) Table 86. Apotex Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 87. Apotex Second Generation Cephalosporins Product Offered Table 88. Apotex Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 89. Apotex Main Business Table 90. Apotex Latest Developments Table 91. Esseti Farmaceutici Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 92. Esseti Farmaceutici Second Generation Cephalosporins Product Offered Table 93. Esseti Farmaceutici Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 94. Esseti Farmaceutici Main Business Table 95. Esseti Farmaceutici Latest Developments Table 96. GSK Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 97. GSK Second Generation Cephalosporins Product Offered Table 98. GSK Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 99. GSK Main Business Table 100. GSK Latest Developments Table 101. Lilly Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 102. Lilly Second Generation Cephalosporins Product Offered Table 103. Lilly Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 104. Lilly Main Business Table 105. Lilly Latest Developments Table 106. Medochemie Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 107. Medochemie Second Generation Cephalosporins Product Offered Table 108. Medochemie Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 109. Medochemie Main Business Table 110. Medochemie Latest Developments Table 111. Northeast Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 112. Northeast Pharmaceutical Second Generation Cephalosporins Product Offered Table 113. Northeast Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 114. Northeast Pharmaceutical Main Business Table 115. Northeast Pharmaceutical Latest Developments Table 116. NCPC Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 117. NCPC Second Generation Cephalosporins Product Offered Table 118. NCPC Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 119. NCPC Main Business Table 120. NCPC Latest Developments Table 121. Nanchang Lijian Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 122. Nanchang Lijian Pharmaceutical Second Generation Cephalosporins Product Offered Table 123. Nanchang Lijian Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 124. Nanchang Lijian Pharmaceutical Main Business Table 125. Nanchang Lijian Pharmaceutical Latest Developments Table 126. Sichuan Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 127. Sichuan Pharmaceutical Second Generation Cephalosporins Product Offered Table 128. Sichuan Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 129. Sichuan Pharmaceutical Main Business Table 130. Sichuan Pharmaceutical Latest Developments Table 131. Shandong Runze Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 132. Shandong Runze Pharmaceutical Second Generation Cephalosporins Product Offered Table 133. Shandong Runze Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 134. Shandong Runze Pharmaceutical Main Business Table 135. Shandong Runze Pharmaceutical Latest Developments Table 136. Shandong Luoxin Pharmaceutical Group Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 137. Shandong Luoxin Pharmaceutical Group Second Generation Cephalosporins Product Offered Table 138. Shandong Luoxin Pharmaceutical Group Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 139. Shandong Luoxin Pharmaceutical Group Main Business Table 140. Shandong Luoxin Pharmaceutical Group Latest Developments Table 141. Guangdong Bozhou Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 142. Guangdong Bozhou Pharmaceutical Second Generation Cephalosporins Product Offered Table 143. Guangdong Bozhou Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 144. Guangdong Bozhou Pharmaceutical Main Business Table 145. Guangdong Bozhou Pharmaceutical Latest Developments Table 146. Guangdong Jincheng Jinsu Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 147. Guangdong Jincheng Jinsu Pharmaceutical Second Generation Cephalosporins Product Offered Table 148. Guangdong Jincheng Jinsu Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 149. Guangdong Jincheng Jinsu Pharmaceutical Main Business Table 150. Guangdong Jincheng Jinsu Pharmaceutical Latest Developments Table 151. Guangzhou Baiyunshan Tianxin Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 152. Guangzhou Baiyunshan Tianxin Pharmaceutical Second Generation Cephalosporins Product Offered Table 153. Guangzhou Baiyunshan Tianxin Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 154. Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business Table 155. Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments Table 156. Guangxi Kelun Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 157. Guangxi Kelun Pharmaceutical Second Generation Cephalosporins Product Offered Table 158. Guangxi Kelun Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 159. Guangxi Kelun Pharmaceutical Main Business Table 160. Guangxi Kelun Pharmaceutical Latest Developments Table 161. Yuekang Pharmaceutical Group Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 162. Yuekang Pharmaceutical Group Second Generation Cephalosporins Product Offered Table 163. Yuekang Pharmaceutical Group Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 164. Yuekang Pharmaceutical Group Main Business Table 165. Yuekang Pharmaceutical Group Latest Developments Table 166. Shantou Jinshi Injection Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 167. Shantou Jinshi Injection Second Generation Cephalosporins Product Offered Table 168. Shantou Jinshi Injection Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 169. Shantou Jinshi Injection Main Business Table 170. Shantou Jinshi Injection Latest Developments Table 171. Zhejiang Yatai Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 172. Zhejiang Yatai Pharmaceutical Second Generation Cephalosporins Product Offered Table 173. Zhejiang Yatai Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 174. Zhejiang Yatai Pharmaceutical Main Business Table 175. Zhejiang Yatai Pharmaceutical Latest Developments Table 176. Shenzhen Xinlitai Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 177. Shenzhen Xinlitai Pharmaceutical Second Generation Cephalosporins Product Offered Table 178. Shenzhen Xinlitai Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 179. Shenzhen Xinlitai Pharmaceutical Main Business Table 180. Shenzhen Xinlitai Pharmaceutical Latest Developments Table 181. Shenzhen Huarun Jiuxin Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 182. Shenzhen Huarun Jiuxin Pharmaceutical Second Generation Cephalosporins Product Offered Table 183. Shenzhen Huarun Jiuxin Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 184. Shenzhen Huarun Jiuxin Pharmaceutical Main Business Table 185. Shenzhen Huarun Jiuxin Pharmaceutical Latest Developments Table 186. Zhuhai Union Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 187. Zhuhai Union Pharmaceutical Second Generation Cephalosporins Product Offered Table 188. Zhuhai Union Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 189. Zhuhai Union Pharmaceutical Main Business Table 190. Zhuhai Union Pharmaceutical Latest Developments Table 191. Ruiyang Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 192. Ruiyang Pharmaceutical Second Generation Cephalosporins Product Offered Table 193. Ruiyang Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 194. Ruiyang Pharmaceutical Main Business Table 195. Ruiyang Pharmaceutical Latest Developments Table 196. Fujian Fukang Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 197. Fujian Fukang Pharmaceutical Second Generation Cephalosporins Product Offered Table 198. Fujian Fukang Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 199. Fujian Fukang Pharmaceutical Main Business Table 200. Fujian Fukang Pharmaceutical Latest Developments Table 201. Suzhou Erye Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 202. Suzhou Erye Pharmaceutical Second Generation Cephalosporins Product Offered Table 203. Suzhou Erye Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 204. Suzhou Erye Pharmaceutical Main Business Table 205. Suzhou Erye Pharmaceutical Latest Developments Table 206. Furen Pharmaceutical Group Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 207. Furen Pharmaceutical Group Second Generation Cephalosporins Product Offered Table 208. Furen Pharmaceutical Group Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 209. Furen Pharmaceutical Group Main Business Table 210. Furen Pharmaceutical Group Latest Developments Table 211. Chongqing Kerui Pharmaceutical Group Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 212. Chongqing Kerui Pharmaceutical Group Second Generation Cephalosporins Product Offered Table 213. Chongqing Kerui Pharmaceutical Group Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 214. Chongqing Kerui Pharmaceutical Group Main Business Table 215. Chongqing Kerui Pharmaceutical Group Latest Developments Table 216. Shanxi Xidunsi Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 217. Shanxi Xidunsi Pharmaceutical Second Generation Cephalosporins Product Offered Table 218. Shanxi Xidunsi Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 219. Shanxi Xidunsi Pharmaceutical Main Business Table 220. Shanxi Xidunsi Pharmaceutical Latest Developments Table 221. Qilu Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 222. Qilu Pharmaceutical Second Generation Cephalosporins Product Offered Table 223. Qilu Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 224. Qilu Pharmaceutical Main Business Table 225. Qilu Pharmaceutical Latest Developments Table 226. Shandong Zibo Xinda Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 227. Shandong Zibo Xinda Pharmaceutical Second Generation Cephalosporins Product Offered Table 228. Shandong Zibo Xinda Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 229. Shandong Zibo Xinda Pharmaceutical Main Business Table 230. Shandong Zibo Xinda Pharmaceutical Latest Developments Table 231. Guangzhou Nanxin Pharmaceutical Basic Information, Second Generation Cephalosporins Manufacturing Base, Sales Area and Its Competitors Table 232. Guangzhou Nanxin Pharmaceutical Second Generation Cephalosporins Product Offered Table 233. Guangzhou Nanxin Pharmaceutical Second Generation Cephalosporins Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2019-2021E) Table 234. Guangzhou Nanxin Pharmaceutical Main Business Table 235. Guangzhou Nanxin Pharmaceutical Latest Developments List of Figures Figure 1. Picture of Second Generation Cephalosporins Figure 2. Second Generation Cephalosporins Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Second Generation Cephalosporins Sales Growth Rate 2016-2026 (KG) Figure 7. Global Second Generation Cephalosporins Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Second Generation Cephalosporins Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Cefotiam Figure 10. Product Picture of Cefuroxime Figure 11. Global Second Generation Cephalosporins Sales Market Share by Type in 2020 Figure 12. Global Second Generation Cephalosporins Revenue Market Share by Type (2016-2021) Figure 13. Second Generation Cephalosporins Consumed in Respiratory Tract Infection Figure 14. Global Second Generation Cephalosporins Market: Respiratory Tract Infection (2016-2021) & (KG) Figure 15. Second Generation Cephalosporins Consumed in Otolaryngological Infection Figure 16. Global Second Generation Cephalosporins Market: Otolaryngological Infection (2016-2021) & (KG) Figure 17. Second Generation Cephalosporins Consumed in Urinary Tract Infection Figure 18. Global Second Generation Cephalosporins Market: Urinary Tract Infection (2016-2021) & (KG) Figure 19. Second Generation Cephalosporins Consumed in Skin and Soft Tissue Infections Figure 20. Global Second Generation Cephalosporins Market: Skin and Soft Tissue Infections (2016-2021) & (KG) Figure 21. Second Generation Cephalosporins Consumed in Bone and Joint Infections Figure 22. Global Second Generation Cephalosporins Market: Bone and Joint Infections (2016-2021) & (KG) Figure 23. Second Generation Cephalosporins Consumed in Gonorrhea Figure 24. Global Second Generation Cephalosporins Market: Gonorrhea (2016-2021) & (KG) Figure 25. Second Generation Cephalosporins Consumed in Other Figure 26. Global Second Generation Cephalosporins Market: Other (2016-2021) & (KG) Figure 27. Global Second Generation Cephalosporins Sales Market Share by Application (2016-2021) Figure 28. Global Second Generation Cephalosporins Revenue Market Share by Application in 2020 Figure 29. Second Generation Cephalosporins Revenue Market by Company in 2020 ($ Million) Figure 30. Global Second Generation Cephalosporins Revenue Market Share by Company in 2020 Figure 31. Global Second Generation Cephalosporins Sales Market Share by Regions (2016-2021) Figure 32. Global Second Generation Cephalosporins Revenue Market Share by Region in 2020 Figure 33. Americas Second Generation Cephalosporins Sales 2016-2021 (KG) Figure 34. Americas Second Generation Cephalosporins Revenue 2016-2021 ($ Millions) Figure 35. APAC Second Generation Cephalosporins Sales 2016-2021 (KG) Figure 36. APAC Second Generation Cephalosporins Revenue 2016-2021 ($ Millions) Figure 37. Europe Second Generation Cephalosporins Sales 2016-2021 (KG) Figure 38. Europe Second Generation Cephalosporins Revenue 2016-2021 ($ Millions) Figure 39. Middle East & Africa Second Generation Cephalosporins Sales 2016-2021 (KG) Figure 40. Middle East & Africa Second Generation Cephalosporins Revenue 2016-2021 ($ Millions) Figure 41. Americas Second Generation Cephalosporins Sales Market Share by Country in 2020 Figure 42. Americas Second Generation Cephalosporins Revenue Market Share by Country in 2020 Figure 43. Americas Second Generation Cephalosporins Sales Market Share by Type in 2020 Figure 44. Americas Second Generation Cephalosporins Sales Market Share by Application in 2020 Figure 45. United States Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 46. Canada Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 47. Mexico Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 48. Brazil Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 49. APAC Second Generation Cephalosporins Sales Market Share by Region in 2020 Figure 50. APAC Second Generation Cephalosporins Revenue Market Share by Regions in 2020 Figure 51. APAC Second Generation Cephalosporins Sales Market Share by Type in 2020 Figure 52. APAC Second Generation Cephalosporins Sales Market Share by Application in 2020 Figure 53. China Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 54. Japan Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 55. Korea Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 56. Southeast Asia Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 57. India Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 58. Australia Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 59. Europe Second Generation Cephalosporins Sales Market Share by Country in 2020 Figure 60. Europe Second Generation Cephalosporins Revenue Market Share by Country in 2020 Figure 61. Europe Second Generation Cephalosporins Sales Market Share by Type in 2020 Figure 62. Europe Second Generation Cephalosporins Sales Market Share by Application in 2020 Figure 63. Germany Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 64. France Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 65. UK Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 66. Italy Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 67. Russia Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 68. Middle East & Africa Second Generation Cephalosporins Sales Market Share by Country in 2020 Figure 69. Middle East & Africa Second Generation Cephalosporins Revenue Market Share by Country in 2020 Figure 70. Middle East & Africa Second Generation Cephalosporins Sales Market Share by Type in 2020 Figure 71. Middle East & Africa Second Generation Cephalosporins Sales Market Share by Application in 2020 Figure 72. Egypt Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 73. South Africa Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 74. Israel Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 75. Turkey Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 76. GCC Country Second Generation Cephalosporins Revenue Growth 2016-2021 ($ Millions) Figure 77. Channels of Distribution Figure 78. Distributors Profiles |
| ※본 조사보고서 [세계의 2세대 세팔로스포린 시장예측 2021년-2026년] (코드 : LPI-2108K201815) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 2세대 세팔로스포린 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |